Phase 1 Trial of ADI-PEG 20 Plus Cisplatin in Patients With Argininousccinate Synthetase Deficient Advanced Tumors

This study is currently recruiting participants.
Verified August 2012 by Polaris Group
Sponsor:
Information provided by (Responsible Party):
Polaris Group
ClinicalTrials.gov Identifier:
NCT01665183
First received: August 8, 2012
Last updated: December 16, 2012
Last verified: August 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: July 2014
  Estimated Primary Completion Date: September 2013 (Final data collection date for primary outcome measure)